Feb 21 (Reuters) - The U.S. Food and Drug Administration approved Mirum Pharmaceuticals' (MIRM.O), opens new tab genetic disorder drug on Friday, making it the first treatment for a rare condition ...
Adial Pharmaceuticals has announced the issuance of patent number 12,226,401, which enhances their genetic-based approach for treating alcohol and opioid use disorders. This new patent focuses on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback